US Patent 9447184 IL-1 binding proteins
Patent 9447184 was granted and assigned to AbbVie Inc. on September, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 6 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+256 characters)
Article
Patent abstract
Proteins that bind IL-1α and IL-1β are described along with their use in compositions and methods for treating, preventing, and diagnosing IL-1-related disorders and for detecting IL-1α and IL-1β in cells, tissues, samples, and compositions.
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Chengbin Wu0
Chung-ming Hsieh0
Dominic J. Ambrosi0
Tariq Ghayur0
Edits on 12 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 14 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09447184 IL-1 binding proteins US Patent 9447184 IL-1 binding proteins
Infobox
Patent Number
09447184
Patent Number
9447184
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 8 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09447184 IL-1 binding proteins
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09447184
Date of patent
September 20, 2016
Patent application number
14141317
Date Filed
December 26, 2013
Patent primary examiner
Find more entities like US Patent 9447184 IL-1 binding proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.